Long-term follow-up data from a phase 2b trial of Moderna and MSD's mRNA-based vaccine against melanoma, intismeran autogene (mRNA-4157), show an impressive 49% reduction in the risk of disease ...
MSD has fleshed out the results of phase 3 trials of its cholesterol-lowering, oral PCSK9 inhibitor, enlicitide decanoate, showing its efficacy was comparable to that of injectable alternatives. The ...
The NEW 5977B High Efficiency Source (HES) GC/MSD builds on a tradition of providing the most trusted single-quadrupole GC/MS system. The ultra-efficient EI source maximizes the number of ions that ...
The DB-17 GC Column is a (50%-Phenyl)- methylpolysiloxane column of mid polarity. The DB-17 GC Column is excellent for confirmation analysis. The DB-17 GC Column is equivalent to USP Phase G3. Agilent ...
Redis, the world's fastest data platform, is releasing Redis Feature Form, a managed feature store platform built to help enterprise ML teams bring features into production with more control, ...
This webinar will introduce you to some considerations and solutions for integration of chromatogram and processing of data using Agilent OpenLAB Chemstation. Topics include useful knowledge for ...
About Ginkgo Bioworks Holdings Inc. Ginkgo Bioworks Holdings, Inc. engages in developing biological engineering products and custom microbes. Its platform enables biotechnology applications across ...
Sunrun, Inc. engages in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems. It sells solar service offerings and installs solar energy systems ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results